SPARC and prostate carcinoma: We also tested the effect of SPARC on the invasive potential of other prostate cancer cells, finding that recombinant human SPARC caused an enhanced invasiveness of the androgen-independent Du-145 and 22Rv1 cells, but not the androgen-dependent LNCaP cells (Additional file 1: Figure S7).